Cargando…

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease increasing cardiovascular disease (CVD) morbidity and mortality. Autoantibodies against apolipoprotein A-1 (AAA-1) are a possible novel CVD risk factor promoting inflammation and disrupting cellular lipid homeostasis, tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Sabrina, Bakker, Stephan J. L., Juillard, Catherine, Vossio, Stefania, Moreau, Dimitri, Brandt, Karim J., Mach, François, Dullaart, Robin P. F., Vuilleumier, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552329/ https://www.ncbi.nlm.nih.gov/pubmed/37798764 http://dx.doi.org/10.1186/s12967-023-04569-7

Ejemplares similares

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease
por: Pagano, Sabrina, et al.
Publicado: (2023)

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019)

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis
por: Satta, Nathalie, et al.
Publicado: (2020)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
por: Lamacchia, Celine, et al.
Publicado: (2023)

Anti-Apolipoprotein A-1 IgG Levels Predict Coronary Artery Calcification in Obese but Otherwise Healthy Individuals
por: Quercioli, Alessandra, et al.
Publicado: (2012)

Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects
por: Vuilleumier, Nicolas, et al.
Publicado: (2019)

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus
por: Dullaart, Robin P. F., et al.
Publicado: (2019)

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015)

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques
por: da Silva, Rafaela F., et al.
Publicado: (2020)

Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms
por: Antiochos, Panagiotis, et al.
Publicado: (2017)

Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
por: Kunutsor, Setor K., et al.
Publicado: (2019)

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)

Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes
por: Vuilleumier, Nicolas, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids
por: van den Berg, Eline H., et al.
Publicado: (2019)

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
por: Vuilleumier, Nicolas, et al.
Publicado: (2021)

SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1
por: Pagano, S., et al.
Publicado: (2021)

Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population
por: Damba, Turtushikh, et al.
Publicado: (2020)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease
por: Goossens, Nicolas, et al.
Publicado: (2017)

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Saeed, Ali, et al.
Publicado: (2017)

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1
por: Pagano, Sabrina, et al.
Publicado: (2021)

Sodium status and kidney involvement during COVID-19 infection
por: Post, Adrian, et al.
Publicado: (2020)

Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
por: Post, Adrian, et al.
Publicado: (2020)

High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome
por: Deetman, Petronella E, et al.
Publicado: (2013)

Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017)

Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
por: Liu, Yaming, et al.
Publicado: (2022)

The Roles of Fatty Acids and Apolipoproteins in the Kidneys
por: Pan, Xiaoyue
Publicado: (2022)

Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39‐R43 of β2‐glycoprotein I
por: Moghbel, Marc, et al.
Publicado: (2022)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

TFAP2 transcription factors are regulators of lipid droplet biogenesis
por: Scott, Cameron C, et al.
Publicado: (2018)

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
por: L’Huillier, Arnaud G., et al.
Publicado: (2022)

Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives
por: Teixeira, P. C., et al.
Publicado: (2012)

Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease
por: Sarmadi, Negar, et al.
Publicado: (2022)

Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study
por: Adam, Safwaan, et al.
Publicado: (2021)

Drug‐induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann–Pick type C cells and mice
por: Moreau, Dimitri, et al.
Publicado: (2019)

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort
por: van den Berg, Eline H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kfk86348b8lhiqqmb69u80alq6